Introduction: The objective of this study was to determine the impact of the stage-based classification of fetal growth restriction (FGR) on the magnitude of FGR, preterm births (PTBs), and birthweight (BW) in a rural population of Madhya Pradesh in Central India. Methods: The program covered 168 public sector centers for pregnant women and infants that provided services to nearly 220,000 people. The third-trimester assessments included fetal biometry, growth and environment assessments, and Doppler assessments. Fetal growth was staged using the Barcelona protocol as stages 1–4 FGR, small for gestational age, and no FGR. The data from the last ultrasound assessment before childbirth were considered. Regular training programs covering preconception care, antenatal and postnatal care were organized in the local language for the public sector community health workers of the program district. Childbirth outcomes were collected from the obstetric service of the local public sector hospital. Results: The analysis included 1,229 pregnancies from 2019 to 2023. The overall magnitude of FGR using estimated fetal weight <10th centile was 19.61% and reduced to 13.34% with the stage-based classification. The magnitude of FGR using the stage-based classification reduced from 27.59% in 2019 to 8.95% in 2023. The PTB in the stage-based FGR subgroup declined from 35.0% in 2019 to 3.45% in 2023 and 96.55% of the stage 1 FGR babies in 2023 were delivered at term. The overall mean BW in the program area improved from 2,772.41 (357.11) g in 2019 to 2,819.68 (377.31) g in 2023. The perinatal mortality rate (8.95 per 1,000 pregnancies) in the program area for 2019–2023 was much lower than the 31.9 per 1,000 pregnancies reported for Madhya Pradesh. Conclusion: The change to a stage-based classification of FGR integrated with low-dose aspirin and fetal Doppler studies reduced the incidence of FGR and PTB and perinatal mortality and increased BW in this rural community.

1.
GBD 2015 Child Mortality Collaborators
.
Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015
.
Lancet
.
2016
;
388
(
10053
):
1725
74
.
2.
International Institute for Population Sciences (IIPS) and ICF. 2021. National Family Health Survey (NFHS-5), 2019-2021: India: Volume 1, Mumbai: IIPS.
3.
Choorakuttil
RM
,
Patel
H
,
Bavaharan
R
,
Devarajan
P
,
Kanhirat
S
,
Shenoy
RS
, et al
.
Samrakshan: an Indian Radiological and Imaging Association program to reduce perinatal mortality in India
.
Indian J Radiol Imaging
.
2019
;
29
(
4
):
412
7
.
4.
Maternal and neonatal health in Madhya Pradesh: Trends, insights and scope
. Available from: https://www.ihat.in/resources/mnh-in-madhya-pradesh-trends-insights-and-scope/ (Accessed February 2, 2024).
5.
Sharma
LK
,
Choorakuttil
RM
,
Jadon
DS
,
Nirmalan
PK
.
Impact of the community-integrated model of samrakshan on perinatal mortality and morbidity in Guna district of Central India
.
Indian J Radiol Imaging
.
2023
;
33
(
1
):
65
9
.
6.
Bhide
A
,
Acharya
G
,
Baschat
A
,
Bilardo
CM
,
Brezinka
C
,
Cafici
D
, et al
.
ISUOG Practice Guidelines (updated): use of Doppler velocimetry in obstetrics
.
Ultrasound Obstet Gynecol
.
2021
;
58
(
2
):
331
9
.
7.
Roberts
L
,
Chaemsaithong
P
,
Sahota
DS
,
Nicolaides
KH
,
Poon
LCY
.
Protocol for measurement of mean arterial pressure at 10-40 weeks’ gestation
.
Pregnancy Hypertens
.
2017
;
10
:
155
60
.
8.
Figueras
F
,
Gratacós
E
.
Update on the diagnosis and classification of fetal growth restriction and proposal of a stage-based management protocol
.
Fetal Diagn Ther
.
2014
;
36
(
2
):
86
98
.
9.
Brown
MA
,
Magee
LA
,
Kenny
LC
,
Karumanchi
SA
,
McCarthy
FP
,
Saito
S
, et al
.
Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice
.
Hypertension
.
2018
;
72
(
1
):
24
43
.
10.
O’Gorman
N
,
Wright
D
,
Poon
LC
,
Rolnik
DL
,
Syngelaki
A
,
Wright
A
, et al
.
Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks’ gestation
.
Ultrasound Obstet Gynecol
.
2017
;
49
(
6
):
751
5
.
11.
Cauzzo
C
,
Chiavaroli
V
,
Di Valerio
S
,
Chiarelli
F
.
Birth size, growth trajectory and later cardio-metabolic risk
.
Front Endocrinol
.
2023
;
14
:
1187261
.
12.
Ni
Y
,
Beckmann
J
,
Hurst
JR
,
Morris
JK
,
Marlow
N
.
Size at birth, growth trajectory in early life, and cardiovascular and metabolic risks in early adulthood: EPICure study
.
Arch Dis Child Fetal Neonatal Ed
.
2021
;
106
(
2
):
149
55
.
13.
Parkinson
JR
,
Hyde
MJ
,
Gale
C
,
Santhakumaran
S
,
Modi
N
.
Preterm birth and the metabolic syndrome in adult life: a systematic review and meta-analysis
.
Pediatrics
.
2013
;
131
(
4
):
e1240
63
.
14.
Bujold
E
,
Roberge
S
,
Nicolaides
KH
.
Low-dose aspirin for prevention of adverse outcomes related to abnormal placentation
.
Prenat Diagn
.
2014
;
34
(
7
):
642
8
.
15.
Roberge
S
,
Nicolaides
KH
,
Demers
S
,
Villa
P
,
Bujold
E
.
Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis
.
Ultrasound Obstet Gynecol
.
2013
;
41
(
5
):
491
9
.
16.
Veglia
M
,
Cavallaro
A
,
Papageorghiou
A
,
Black
R
,
Impey
L
.
Small-for-gestational-age babies after 37 weeks: impact study of risk-stratification protocol
.
Ultrasound Obstet Gynecol
.
2018
;
52
(
1
):
66
71
.
You do not currently have access to this content.